Introduction
Scurvy, resulted from vitamin C deficiency, is a very rare disease in the United States nowadays. It is mostly found in people whose age, disability, or apathy lead to an inadequate dietary intake. 1 Other risk factors include intestinal malabsorption and dialysis 1 ; infants whose intake includes only cow's milk for the first year of life; development disorders including autism 1 ; eating disorders; certain individuals who have higher requirements of vitamin C including smokers; patients with type I diabetes, AIDS, iron overload disorders, renal failure requiring hemodialysis, or with diseases affecting the small intestine; residents in refugee camp 2 ; and children with iron overload due to medical conditions such as sickle cell disease or thalassemia or a history of bone marrow transplantation. 3 The clinical presentation of scurvy includes follicular hyperkeratosis, skin and mucosal bleeding (petechiae, ecchymoses), and anemia in severe/prolonged patients. Due to its rarity, scurvy-associated anemia is no longer well recognized by clinicians, which, resulting in extensive evaluation/lab workup for other systemic illness, increases health care costs and potential morbidity. Here we documented an anemic patient associated with Scurvy from clinical presentation to lab findings.
Case Presentation
A 56-year-old white man was sent to the emergency room with shortness of breath, ankle swelling, and bruising on both legs. He described onset of skin rash about 1 year ago, and leg bruising 2 weeks ago. He felt fatigue recently and developed shortness of breath several days ago. He denied any trauma, frank bleeding from any source, previous or current medication usage. Regarding patient history, he admitted having used alcohol daily for the last 40 years and smokes 1 to 2 packs per day. He had poor gum with bad dentition requiring extraction, and poor diet habits for a long time. He denied anorexia, involuntary weight change, fever, or night sweats. Physical examination revealed extensive follicular hyperkeratosis, multiple ecchymosis on the inner thighs and multiple perifollicular petechiae on both legs. His heart rate, blood pressure, and body temperature all were within normal limits. His lab values were as follows: white blood cell (WBC) = 3.4 K/uL (low), red blood cell (RBC) = 1.9 millions/uL (low), hemoglobin (HGB) = 7.6 g/ dL (low), hematocrit = 22.2% (low), mean cell volume = 116.8 fL (high), mean cell hemoglobin = 40 pg (high), red blood cell distribution width = 17.7% (high), platelets (PLT) = 133 K/uL (normal). Patient's prothrombin time (PT), partial thromboplastin time (PTT), and fibrinogen were within normal limits. Peripheral blood smear showed macrocytes ( Figure 1A ), mild anisocytosis, and rare nucleated RBCs. WBCs showed normal maturation, with few metamyelocytes present. Few giant PLT were identified. Level of serum vitamin C was 0 mg/dL, Ferritin = 720 ng/mL (normal), vitamin B 12 = 317 pg/mL (normal), and folate = 4.3 ng/mL (normal).
Bone Marrow Biopsy
A bone marrow biopsy was performed. The biopsy showed hypercellular marrow for age (90%) with trilineage hematopoiesis ( Figure 1B ). There was absolute erythroid hyperplasia and megaloblastic change ( Figure 1B and C). The number and morphology of megakaryocytes were within normal limits. The iron stain revealed abundant amount of iron storage ( Figure 1D ), and retic stain revealed no increase in reticulin fibers. The aspirate smear revealed that the erythroid lineage had marked hyperplasia, left shift, and megaloblastic change. Flow cytometry analysis showed no immunophenotypic evidence for abnormal myeloid maturation, an increase in blasts or lymphoproliferative disorder. Cytogenetics and fluores-2 Clinical Medicine Insights: Case Reports cence in situ hybridization for myelodysplastic syndrome panels were negative.
The patient was diagnosed as scurvy-associated anemia and was put on vitamin C therapy (500 mg, orally, twice a day), supplemented with multivitamin pills. Two weeks later, he reported back that his dyspnea was gone, skin discoloration disappeared, and his lab results showed HGB increased to 11.8 g/dL. The patient was continuing with oral vitamin C and multivitamin pills.
Discussion
Vitamin C (ascorbic acid) is an essential part of the well-being of HGB synthesis. Food that are high in vitamin C, include broccoli, brussels sprouts, and cauliflower, green and red peppers, spinach, cabbage, turnip greens, and other leafy greens, sweet and white potatoes, tomatoes and tomato juice, and winter squash. 4 Vitamin C regulates iron metabolism and connective tissue remodeling via co-enzymatic activity of hydroxylation. A healthy adult maintains about 1500 mg Vitamin C in the body pool. When this pool drops below 350 mg, clinical symptoms, including follicular hyperkeratosis, perifollicular petechia, gum bleeding, and anemia start to appear. Scurvy-associated anemia can be microcytic, normocytic, or macrocytic. 5 Diagnostically and therapeutically, the importance is self-evident to differentiate it from anemia of other etiologies. Table  1 summarizes the most important features of vitamin C, iron, folate, and vitamin B 12 deficiency. All anemias present clinically with fatigue, shortness of breath, and muscle weakness. However, vitamin C deficiency has some unique changes such as follicular hyperkeratosis, coiled/corkscrew hairs, gingivitis, and perifollicular hemorrhage. Complete blood count and bone marrow biopsy are not that helpful to differentiate vitamin C deficiency from vitamin B 12 or folate deficiency, in which all share similar features such as megaloblastic changes, but it is very helpful to differentiate it from other hematologic abnormalities such as myelodysplasia, anaplastic anemia, infectious or metastatic disorders. Due to bleeding tendency (petechia, ecchymosis, etc) for vitamin C deficiency, coagulation study for PT and activated PTT is also necessary to rule out coagulation-related disorders. Ultimately, serum level of vitamin C is the gold standard for making the diagnosis. Treatment-wise, patient should gradually recover within 1 week after the initiation of vitamin C intake.
The mechanism of the hematologic changes seen in vitamin C deficiency has been targeted in previous reports (Figure 2) . It was long proposed that vitamin C is essential to folate and vitamin B 12 metabolism. [3] [4] [5] [6] It is reported that vitamin C-only regimen could address the hematologic derangements in some case of megaloblastic anemia. [7] [8] [9] In a cross-sectional study, plasma folate concentration was 25% higher in vitamin C supplement users comparing to the control group. 10 In another study, taking vitamin C alone was associated with a significant increase in red-cell folate, serum folate concentrations, and homocysteine concentrations. 11 In another cross-sectional study, it is found that some folate metabolism-associated gene expression was influenced by the combination of vitamin C and natural folate intakes. 12 In-vitro experiments have demonstrated that vitamin C assisted the converting of 5-Methyldihydrofolic 
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acid into 5-Methyltetrahydrofolic acid, and therefore protected the reduced form of folates from oxidation (to maintain folate bioavailability). 13, 14 The recommended daily dose of vitamin C is controversial, varying from 75 to 200 mg/d for healthy adults to ensure tissue saturation between 60% to 100%. 4, [15] [16] [17] [18] [19] However, some authors argue that this amount is not enough to protect the fully reduced folates and suggest 500 mg/d vitamin C intake instead. 20 
Conclusions
Due to its rarity in modern society, scurvy is usually not in the first line of differential diagnoses for anemia/bleeding patients. Skin manifestations, such as follicular hyperkeratosis and perifollicular hemorrhage, are relatively unique for scurvy-associated anemia/ bleeding and should trigger the clinician to look into vitamin C deficiency. Morphologic examination of peripheral blood and bone marrow is largely not very useful to differentiate among 
